Skip to content
OpenCapital
Get started

Ashland ASH Life Sciences — Depreciation

Other segment segments

Specialty Additives
$13M0.0%
Personal Care And Household
$7M0.0%
Intermediates And Solvents
$1M-66.7%
Unallocated And Other
$0—

Similar metrics at other companies

PTC Therapeutics logo
PTCTLife Science — Depreciation
$3.81M+10.1%
Danaher logo
DHRLife Sciences — Depreciation
$48M+6.7%
Revvity logo
RVTYLife Sciences — Depreciation
$9.91M+37.9%
Thermo Fisher Scientific logo
TMOLife Sciences Solutions — Depreciation of property, plant and equipment
$70M+18.6%
Bio-Rad Laboratories logo
BIOLife Science — Depreciation, Depletion and Amortization
$18.3M+7.6%
GLW
GLWLife Sciences and Emerging Growth Businesses — Depreciation
$26M-10.3%

Other financials

Income statement

See full
Revenue$482.0M+0.6%
Gross profit$147.0M0.0%
Operating income$39.0M-23.5%
Net income$16.0M-48.4%
EPS (diluted)$0.34-47.7%

Balance sheet

See full
Cash & equivalents$343.0M+104%
Total debt$1.5B-0.6%
Total equity$1.9B-27.1%
Total assets$4.5B-14.0%

Cash flow

See full
Operating cash flow$50.0M+456%
CapEx$17.0M-19.0%
Free cash flow$33.0M+375%

Valuation

See full
Market cap$2.93B-9.0%
Enterprise value$4.06B-10.6%
P/S1.6×0.0×

Profitability

See full
Gross margin30%-1.7pp
Operating margin-37.3%—
Net margin-40.8%-48.8pp
FCF margin13.6%+9.7pp

Returns & leverage

See full
Return on equity-33.4%-38.5pp
Debt / equity0.8×+0.2×
Current ratio3.1×+0.7×

Where this comes from

Reported directly by Ashland in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Ashland’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ashland's life sciences — depreciation.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ashland's life sciences — depreciation?
Ashland (ASH) reported life sciences — depreciation of $9M in Q1 2026.
How has Ashland's life sciences — depreciation changed year-over-year?
Ashland's life sciences — depreciation decreased by 59.1% year-over-year, from $22M to $9M.
What is the long-term trend for Ashland's life sciences — depreciation?
Over 4 years (2021 to 2025), Ashland's life sciences — depreciation has grown at a 12.2% compound annual growth rate (CAGR), from $36M to $57M.
What does life sciences — depreciation mean?
This represents the systematic allocation of the cost of tangible assets over their useful lives within the Life Sciences segment. It reflects the wear and tear or obsolescence of manufacturing facilities and equipment used to produce specialty materials. Monitoring this helps investors understand the capital intensity and the ongoing reinvestment requirements of the segment.